This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Catheter-Directed Thrombolysis Market

Catheter-Directed Thrombolysis is a New Therapy Treatment for Coronary Artery Patients to Give Efficient Results. FMI Analysis Key Trends

Catheter-Directed Thrombolysis Market By Delivery Mode, Indication, End User & Region - Forecast 2022-2032

Catheter-Directed Thrombolysis Market Outlook (2022-2032)

[324 Pages Report] The global catheter-directed thrombolysis market is valued at US$ 432.0 Million in 2022. The market is likely to grow at a CAGR of 5.9% and is anticipated to be valued at US$ 814.0 Million by 2032.

The demand for catheter-directed thrombolysis is anticipated to increase as the treatment makes use of processes that remove the clot, be it based on thrombosis or embolization, the low time duration of treatment, and many other factors. This process is one of the most important preferred methods to treat stroke and related health issues.

Report Attribute

Details

Catheter-Directed Thrombolysis Market Value (2022)

US$ 432.0 Million

Catheter-Directed Thrombolysis Market Anticipated Value (2032)

US$ 814.0 Million

Catheter-Directed Thrombolysis Market Projected Growth Rate (2022-2032)

5.9%

Even if we compare the historic CAGR with the anticipated CAGR of the forecast period, there is a positive indication for the market. The historic CAGR of the catheter-directed thrombolysis market from 2016 to 2021 was 5.5%, while the anticipated CAGR is 5.9%. Though not much difference is observed, the good thing is that the market is progressing because of the number of benefits the catheter-directed thrombolytic therapy offers.

Customize this Report

Let us know your requirement to get
100% FREE customization

Prominent Drivers and Restraints in the Catheter-Directed Thrombolysis Market

The seamlessness that this process offers is almost unmatchable. The entire process is done under the purview of x-ray imaging to get the correct site of the clot. Moreover, the technique is used for a number of treatments, which include thrombosis in the vascular bed, deep vein thrombosis, and thrombosis of dialysis fistulate. This is expected to increase the adoption of catheter-directed thrombolysis and makes the entire process an essential form of stroke medication.

Additionally, on comparing with the traditional heart surgery process, the process is extremely safe, and the duration for which the patient is admitted to the hospital is less. Besides that, based on the stats provided by WHO, it was found that around 17.9 million people died from heart disease in 2019, accounting for 32% of global deaths. This is something that has captured the attention of investors in the catheter-directed thrombolysis market, as these are mainly used for treating heart diseases.

 Furthermore, the availability of emergency medical services and favorable health insurance coverage will also fuel the catheter-directed thrombolysis market. All these are anticipated to have a positive impact on the catheter-directed thrombolysis market trends and forecast. However, the application of an IV line in order to administer anesthesia might lead to certain injuries to the skin. This can be a cause of concern for the catheter-directed thrombolysis market.

Fluoroscopy: The “Big Cheese” of Catheter-Directed Thrombolysis Market

The amazing ability to keep a real time track of the movements inside the body part has been made possible because of fluoroscopy. The application of fluoroscopy has been perceived as life-saving surgical treatment. Apart from showing the real time view, this method also helps the medical practitioners to place the catheters inside the body with precision.

Moreover, fluoroscopy is used in a wide variety of examinations like Barium x-rays, placement of stents, orthopedic surgery to carry out variety of treatments which include viewing the gastrointestinal tract, visualizing blood vessels, to guide joint replacements etc. Thus, from the above, it can be clearly inferred that the usage of fluoroscopy is likely to increase the scope of catheter-directed thrombolysis market.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Catheter-Directed Thrombolysis Market: Best Way Forward

Replacing X-rays with Ultrasounds

Continuous exposure to x-rays can lead to health complications. Instead of this, the manufacturers can look for ways to replace x-rays with ultrasound, as these can be applied to any kind of patient, even pregnant women.

Moreover, there are no side effects associated with the usage of ultrasounds, and the image quality provided by the usage of ultrasounds is also good. Thus, the replacement of x-rays with ultrasound might very well improve the catheter-directed thrombolysis market outlook.

Replacing IV method with other methods

Instead of applying an invasive technique to administer anesthesia, the administration can be done through other methods, like administering it in the form of a gas, topical liquid, or through any injection. The problem associated with intravenous medication is that it can lead to infection and damage the site of veins and may also lead to air embolism.

However, replacing the IV line with anesthesia through gas, topical liquid, or an injection will avoid any instances of developing a skin infection or any other kind of complication as these are not pierced into the skin, thereby making the process fully non-invasive, except for the case of injection. The application of any one of these methods can be a positive step for the catheter-directed thrombolysis market.

Regional Analysis

North America

North America is expected to dominate the catheter-directed thrombolysis market share due to easy access to advanced healthcare facilities. According to Future Market Insights, the North American catheter-directed thrombolysis market has a market share of 53.4%, and is expected to grow at a rapid pace during the forecast period. Moreover, the region is meant for rapid technological advances.

According to World Health Organization (WHO), approximately 900,000 people were diagnosed with pulmonary embolism and deep vein thrombosis in the U.S. in 2015. Among all end users, the hospital segment dominates the market for catheter-directed thrombolysis over the forecast period. The majority of cases of pulmonary embolism and deep vein thrombosis are treated in hospitals.

Europe

Europe is considered to be the 2nd largest market for catheter-directed thrombolysis owing to the presence of a robust reimbursement scenario and improved regulatory framework. According to Future Market Insights, the region has a market share of 24.1%, and is expected to grow significantly during the forecast period.

Catheter-directed thrombolysis (CDT) with assisted mechanical thrombolysis in the region is considered the standard form of treatment. Deep vein thrombosis (DVT) is the third most common cardiovascular pathology after coronary artery disease and stroke in the region.

Due to the growing geriatric population and risk factors that include oral contraceptives, the demand for catheter-directed thrombolysis is expected to increase during the forecast period in Europe.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Start-up Ecosystem

Start-ups are developing new products with their unique ideas to solve several problems, especially in medical fields for patients. Start-ups in the catheter-directed thrombolysis market are making new devices which help to prevent cardiovascular disease. Some of the start-ups are:

Corveus Medical:

Corveus Medical is a US-based start-up company which has developed a new device to prevent heart failure in recent years. The innovative device developed by a company named “neuromodulation device” helps to access heart tissues uniquely and safely.

Moray Medical:

Moray Medical is another US-based start-up which improves leaky heart valves by providing microfluidic robotic methods. The start-up treats its patients safely with cost-effective therapies.

Competitive Landscape

The market is consolidated by the prominent vendors present all around the region in recent years. They are using several marketing tactics to acquire lion’s share and are anticipated to grow the catheter-directed thrombolysis market share during the forecast period.

Some of the marketing methodologies adopted by key players are partnerships, acquisitions, mergers, product launches, and collaborations among others. Global players such as Angio Dynamics, Inc. and Boston Scientific Corporation account for considerable market size. Several regional level players are also operating across key growth regions.

Recent Developments in the Catheter-Directed Thrombolysis Market:

  • AngioDyamics Inc. is a prominent player when it comes to offering catheter-directed thrombolysis devices. Its Uni-FuseTM Infusion Catheter offers a highly effective treatment for clots. The catheter’s sturdier construction allows inserting stronger catheters with enhanced usability
  • In September 2021, Boston Scientific Corporation purchased an 84% stake in Devoro Medical, further expanding its footprint in the blood clot removal platform of its existing thrombectomy portfolio. The deal saw Boston Scientific put down about US$ 269 Million upfront.
  • ivascular SLU received the CE Mark approval for its BX covered stent iCover in May 2021. Balloon-expanding (BX) covered stents are commonly used for treating arteriosclerotic lesions in renal and iliac arteries, and for the treatment of aneurisms and ruptures. iCover can adapt to the most tortuous vessels due to its high flexibility and outstanding post-expansion capacity. It also offers excellent visibility.

Some of the key participants present in the market include

  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • iVascular SLU
  • Straub Medical AG

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.9% from 2022 to 2032

Base Year for Estimation

2022

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Delivery Mode
  • Indication
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

Customization

Available Upon Request

Key Segments

By Delivery Mode:

  • Direct Delivery to Blood Clot Catheter-directed Thrombolysis
  • Catheter-directed Thrombolysis by Positioning Medical Device at Clot Site

By Indication:

  • Catheter-directed Thrombolysis for Pulmonary Embolism (PE)
  • Catheter-directed Thrombolysis for Deep Vein Thrombosis (DVT)
  • Catheter-directed Thrombolysis for Strokes
  • Catheter-directed Thrombolysis for Other Indications

By End User:

  • Hospitals
  • Surgical Centers
  • Radiology Clinics

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The catheter-directed thrombolysis market is predicted to advance at a CAGR of 5.9% from 2022-to 2032.

The catheter-directed thrombolysis market is valued at US$ 432 million as on 2022

The catheter-directed thrombolysis market is likely to hold a valuation of US$ 814.0 million by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Delivery Mode

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Delivery Mode, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Delivery Mode, 2022-2032

        5.3.1. Directly Delivery To Blood Clot

        5.3.2. Positioning Medical Device At Clot Site

    5.4. Y-o-Y Growth Trend Analysis By Delivery Mode, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Delivery Mode, 2022-2032

6. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032

        6.3.1. Pulmonary Embolism (PE)

        6.3.2. Deep Vein Thrombosis (DVT)

        6.3.3. Stroke

        6.3.4. Other

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

7. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Center

        7.3.3. Radiology Clinics

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Delivery Mode

        9.2.3. By Indication

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Delivery Mode

        9.3.3. By Indication

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Delivery Mode

        10.2.3. By Indication

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Delivery Mode

        10.3.3. By Indication

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Delivery Mode

        11.2.3. By Indication

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Delivery Mode

        11.3.3. By Indication

        11.3.4. By End User

    11.4. Key Takeaways

12. Asia Pacific Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Malaysia

            12.2.1.6. Singapore

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of APAC

        12.2.2. By Delivery Mode

        12.2.3. By Indication

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Delivery Mode

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Key Takeaways

13. MEA Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Delivery Mode

        13.2.3. By Indication

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Delivery Mode

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Key Takeaways

14. Key Countries Catheter-Directed Thrombolysis Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Delivery Mode

            14.1.2.2. By Indication

            14.1.2.3. By End User

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Delivery Mode

            14.2.2.2. By Indication

            14.2.2.3. By End User

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Delivery Mode

            14.3.2.2. By Indication

            14.3.2.3. By End User

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Delivery Mode

            14.4.2.2. By Indication

            14.4.2.3. By End User

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Delivery Mode

            14.5.2.2. By Indication

            14.5.2.3. By End User

    14.6. U.K.

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Delivery Mode

            14.6.2.2. By Indication

            14.6.2.3. By End User

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Delivery Mode

            14.7.2.2. By Indication

            14.7.2.3. By End User

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Delivery Mode

            14.8.2.2. By Indication

            14.8.2.3. By End User

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Delivery Mode

            14.9.2.2. By Indication

            14.9.2.3. By End User

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Delivery Mode

            14.10.2.2. By Indication

            14.10.2.3. By End User

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Delivery Mode

            14.11.2.2. By Indication

            14.11.2.3. By End User

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Delivery Mode

            14.12.2.2. By Indication

            14.12.2.3. By End User

    14.13. Malaysia

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Delivery Mode

            14.13.2.2. By Indication

            14.13.2.3. By End User

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Delivery Mode

            14.14.2.2. By Indication

            14.14.2.3. By End User

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Delivery Mode

            14.15.2.2. By Indication

            14.15.2.3. By End User

    14.16. New Zealand

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Delivery Mode

            14.16.2.2. By Indication

            14.16.2.3. By End User

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Delivery Mode

            14.17.2.2. By Indication

            14.17.2.3. By End User

    14.18. South Africa

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Delivery Mode

            14.18.2.2. By Indication

            14.18.2.3. By End User

    14.19. Israel

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Delivery Mode

            14.19.2.2. By Indication

            14.19.2.3. By End User

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Delivery Mode

        15.3.3. By Indication

        15.3.4. By End User

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Angio Dynamics, Inc.

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Boston Scientific Corporation

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. iVascular SLU

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Straub Medical AG

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Inari Medical, Inc.

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Medtronic Plc

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Penumbra, Inc.

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Straub Medical AG

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Teleflex Incorporated

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Thrombolex Inc.

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 02: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032

Table 03: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 04: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 05: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 06: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032

Table 07: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 08: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 09: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032

Table 11: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 12: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032

Table 15: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 16: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 17: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032

Table 19: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 20: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 21: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032

Table 23: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 24: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032

Figure 02: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032

Figure 03: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032

Figure 04: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by Region, 2022-2032

Figure 05: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 06: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 07: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 08: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032

Figure 09: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032

Figure 10: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032

Figure 11: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 12: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 13: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 14: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 15: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 16: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 17: Global Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032

Figure 18: Global Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032

Figure 19: Global Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032

Figure 20: Global Catheter-Directed Thrombolysis Market Attractiveness by Region, 2022-2032

Figure 21: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032

Figure 22: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032

Figure 23: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032

Figure 24: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032

Figure 29: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032

Figure 30: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032

Figure 31: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 32: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 33: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 34: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 35: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 36: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 37: North America Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032

Figure 38: North America Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032

Figure 39: North America Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032

Figure 40: North America Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032

Figure 42: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032

Figure 43: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032

Figure 44: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032

Figure 49: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032

Figure 50: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032

Figure 51: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 52: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 53: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 54: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 55: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 56: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 57: Latin America Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032

Figure 58: Latin America Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032

Figure 59: Latin America Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032

Figure 60: Latin America Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032

Figure 61: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032

Figure 62: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032

Figure 63: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032

Figure 64: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032

Figure 69: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032

Figure 70: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032

Figure 71: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 72: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 73: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 74: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 75: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 76: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 77: Europe Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032

Figure 78: Europe Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032

Figure 79: Europe Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032

Figure 80: Europe Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032

Figure 82: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032

Figure 83: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032

Figure 84: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032

Figure 89: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032

Figure 90: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032

Figure 91: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 92: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 93: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 94: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 95: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 96: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 97: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032

Figure 98: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032

Figure 99: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032

Figure 100: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032

Figure 101: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032

Figure 102: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032

Figure 103: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032

Figure 104: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032

Figure 109: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032

Figure 110: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032

Figure 111: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 112: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 113: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 114: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 115: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: MEA Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032

Figure 118: MEA Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032

Figure 119: MEA Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032

Figure 120: MEA Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Balloon Catheter Market

Published : January 2022

Healthcare

Stent Graft Balloon Catheter Market

Published : June 2016

Healthcare

Continuous Peripheral Nerve Block Catheter Market

Published : January 2018

Healthcare

Central Venous Catheter Market

Published : November 2016

Google translate

Catheter-Directed Thrombolysis Market